Pfizer, GSK commit supplying developing world with vaccines

Pfizer and GlaxoSmithKline have announced separate agreements with the GAVI Alliance to supply pneumococcal vaccines to developing countries.

Related Content:

ManufacturingFormulation and Drug DeliveryDosage FormsManufacturing, Biologic Drugs

The Impact of Europe’s Decision on the Use of Titanium Dioxide

Driving Quality from the Top: Merck Manufacturing Leader’s Pitch to PDA Regulatory Conference Audience

PDA 2025: Strategic AI Adoption in Bio/Pharma Manufacturing